Signal active
Organization
Contact Information
Overview
Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology
About
Life Science, Pharmaceutical, Biopharma, Oncology
2020
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Libera Bio headquartered in Europe, operates in the Life Science, Pharmaceutical, Biopharma, Oncology sector. The company focuses on Life Science and has secured $85.1M in funding across 64 round(s). With a team of 11-50 employees, Libera Bio is actively contributing to advancements in Life Science. Their latest funding round, Grant - Libera Bio, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
1
0
$1.3M
Details
3
Libera Bio has raised a total of $1.3M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | |||
2021 | Seed | |||
2022 | Seed | 1.3M |
Investors
Libera Bio is funded by 8 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Libera Bio | - | FUNDING ROUND - Libera Bio | 1.3M |
Xesgalicia | - | FUNDING ROUND - Xesgalicia | 1.3M |
Libera Bio | - | FUNDING ROUND - Libera Bio | undefined |
The EmprendeXXI Awards | - | FUNDING ROUND - The EmprendeXXI Awards | undefined |
Recent Activity
There is no recent news or activity for this profile.